DLL4 and Sepsis: We also explored the mechanisms by which DLL4+ neutrophils exacerbate endothelial barrier dysfunction and ALI and demonstrated the potential of developing an inhibitor to mitigate DLL4+ neutrophil–induced endothelial cell PANoptosis, aiming to reduce sepsis severity.